Ilves, Marit Kinaret, Pia Ndika, Joseph Karisola, Piia Marwah, Veer Fortino, Vittorio Fedutik, Yuri Correia, Manuel Ehrlich, Nicky Loeschner, Katrin Besinis, Alexandros Vassallo, Joanne Handy, Richard Wolff, Henrik Savolainen, Kai Greco, Dario Alenius, Harri Additional file 5: of Surface PEGylation suppresses pulmonary effects of CuO in allergen-induced lung inflammation Figure S1. Murine model of allergic airway inflammation. BALB/c mice were sensitized intraperitoneally (ip) with a mixture of ovalbumin and aluminium/magnesium hydroxide (OVA/Alum) on day 1 and 10. After a 10-day recovery period, 2.5, 10 or 40 μg/mouse of CuO nanomaterials dispersed in PBS with or without OVA were administered repeatedly to mice by oropharyngeal aspiration on days 20–23. Mice were sacrificed on day 24 for sample collection of bronchoalveolar lavage fluid (BAL) and lung tissue. ENM, engineered nanomaterial; PBS, phosphate buffered saline. (TIF 444 kb) CuO;Engineered nanomaterial;Health effects;Inflammation;Asthma;Allergic airway inflammation;Risk assessment 2019-07-05
    https://springernature.figshare.com/articles/figure/Additional_file_5_of_Surface_PEGylation_suppresses_pulmonary_effects_of_CuO_in_allergen-induced_lung_inflammation/8795753
10.6084/m9.figshare.8795753.v1